Haydar Frangoul

9PUBLICATIONS
10CO-AUTHORS
HaematologyGene and molecular therapyRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 04, 2026
Is the use of GCSF to mobilize peripheral blood stem cells in sickle cell disease the answer to poor mobilization? Not so fast.

|Jun 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.

|Apr 03, 2026
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia.

Haydar Frangoul, Rabi Hanna, Mark C Walters

|Apr 03, 2026
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.

Rabi Hanna, Haydar Frangoul, Luis Pineiro

|Apr 03, 2026
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.

Ashish O Gupta, Akshay Sharma, Haydar Frangoul

|Dec 08, 2025
Prime Editing for p47phox-Deficient Chronic Granulomatous Disease.

Jennifer L Gori, Elie Haddad, Haydar Frangoul

Pageof 2

Frequent Collaborators

4 joint publications

Akshay Sharma

3 joint publications

Franco Locatelli

3 joint publications

Selim Corbacioglu

3 joint publications

Mark C Walters